BRAHMS Copeptin assay: consultation

The NICE Medical Technologies Evaluation Programme has undertaken an evaluation of BRAHMS copeptin assay to rule myocardial infarction in patients with acute chest pain. These consultation documents contain information on the committee's draft recommendations and details on how medical technology evaluations are conducted.

Consultation on these documents will open Monday 7 March 2011 at 9.00am and close Monday 4 April 2011 at 5.00pm. We would like to receive comments on these documents from anyone who has an interest in the BRAHMS copeptin assay or cardiology as a general area.

Comments should be made via the website. Faxed or e-mailed comments can be sent to EP099copeptin@nice.org.uk using the consultation comments form below.

This page was last updated: 18 August 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.